Pertussis immunisation

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase IV: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase IV

2 trials
  • Varsinais-Suomen hyvinvointialue Academic
    POLIOVIRUS (INACTIVATED) TYPE 3 (SAUKETT STRAIN), PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 2 (MEF-1 STRAIN), PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED, POLIOVIRUS (INACTIVATED) TYPE 1 (MAHONEY STRAIN), DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED
    2024-510787-23-00 1 country 2024 n=138
    Ended
  • Varsinais-Suomen hyvinvointialue Academic
    DIPHTHERIA TOXOID, TETANUS TOXOID, PERTUSSIS TOXOID, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ, PERTUSSIS PERTACTIN, PERTUSSIS FIMBRIAL AGGLUTINOGENS (FIM) 2 AND 3
    2024-511478-56-00 1 country 2024 n=100
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Varsinais-Suomen hyvinvointialue Academic 2 Phase IV 0
New trials by year
2024
2
← All indication landscapes